Published in Obesity (Silver Spring) on April 24, 2008
The use of sibutramine in the management of obesity and related disorders: an update. Vasc Health Risk Manag (2009) 1.09
Socio-demographic and lifestyle factors associated with overweight in a representative sample of 11-15 year olds in France: results from the WHO-Collaborative Health Behaviour in School-aged Children (HBSC) cross-sectional study. BMC Public Health (2011) 1.07
Overweight and obesity and associated factors among school-aged adolescents in Ghana and Uganda. Int J Environ Res Public Health (2011) 0.98
Prevalence of overweight and abdominal obesity in Greek children 6-12 years old: Results from the National Epidemiological Survey. Hippokratia (2011) 0.88
Waist circumference, waist-to-hip ratio and waist-to-height ratio reference percentiles for abdominal obesity among Greek adolescents. BMC Pediatr (2015) 0.88
The effect of alcohol consumption on later obesity in early adulthood--a population-based longitudinal study. Alcohol Alcohol (2010) 0.86
Association of high blood pressure with body mass index, smoking and physical activity in healthy young adults. Open Cardiovasc Med J (2015) 0.84
Replication of established common genetic variants for adult BMI and childhood obesity in Greek adolescents: the TEENAGE study. Ann Hum Genet (2013) 0.83
High prevalence of overweight among adolescents in Ho Chi Minh City, Vietnam. BMC Public Health (2013) 0.79
Childhood obesity in Greece: the emerging role of primary health care. Hippokratia (2011) 0.75
Prevalence of abdominal obesity in adolescents 2012, birjand, East of iran. Int J Prev Med (2014) 0.75
Influence of country of birth and ethnicity on body mass index among Canadian youth: a national survey. CMAJ Open (2014) 0.75
Prevalence and geographic variation of abdominal obesity in 7- and 9-year-old children in Greece; World Health Organization Childhood Obesity Surveillance Initiative 2010. BMC Public Health (2017) 0.75
Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab (2009) 2.50
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin (2011) 1.53
The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study. Curr Vasc Pharmacol (2013) 1.53
Atorvastatin: safety and tolerability. Expert Opin Drug Saf (2010) 1.47
Seizures after aneurysmal subarachnoid hemorrhage treated with coil embolization. Neurosurgery (2003) 1.46
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. Curr Med Res Opin (2006) 1.38
Is angioedema a class adverse effect of the angiotensin-converting enzyme inhibitors? Ann Allergy Asthma Immunol (2007) 1.38
CORONA, statins, and heart failure: who lost the crown? Angiology (2008) 1.38
Arterial embolization of giant hepatic hemangiomas. Cardiovasc Intervent Radiol (2003) 1.30
Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens) (2009) 1.29
Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.27
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant (2006) 1.24
Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review. Met Based Drugs (2010) 1.18
Transarterial balloon-assisted glue embolization of high-flow arteriovenous fistulas. Neuroradiology (2007) 1.16
IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis. Arch Med Sci (2011) 1.12
Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. Am J Cardiol (2007) 1.09
Pleiotropic effects of statins--clinical evidence. Curr Pharm Des (2009) 1.08
Serum uric acid as an independent predictor of early death after acute stroke. Circ J (2007) 1.06
Spur cells and spur cell anemia in hospitalized patients with advanced liver disease: Incidence and correlation with disease severity and survival. Hepatol Res (2010) 1.05
Gastrectomy for stage IV gastric cancer. a systematic review and meta-analysis. Anticancer Res (2014) 1.05
Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study. J Gastroenterol Hepatol (2009) 1.03
The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity. J Mol Biol (2005) 1.02
Anatomic variations of the right hepatic duct: results and surgical implications from a cadaveric study. Anat Res Int (2012) 1.02
Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study. Arch Med Sci (2013) 1.01
Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin (2010) 1.01
Should adipokines be considered in the choice of the treatment of obesity-related health problems? Curr Drug Targets (2010) 1.01
Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment. World J Hepatol (2012) 1.01
Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis. Med Oncol (2010) 1.01
Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother (2008) 1.00
Marital status and educational level associated to obesity in Greek adults: data from the National Epidemiological Survey. BMC Public Health (2010) 1.00
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod (2011) 1.00
Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. Arch Med Sci (2011) 0.96
Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents (2013) 0.96
Statin discontinuation: an underestimated risk? Curr Med Res Opin (2008) 0.95
Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment? Arch Med Sci (2011) 0.94
Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association? Curr Opin Cardiol (2010) 0.94
Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology (2011) 0.94
Bariatric surgery as a treatment option in patients with type 2 diabetes mellitus. World J Diabetes (2013) 0.94
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. Haematologica (2004) 0.93
Transvenous embolization of a dural carotid-cavernous fistula through the contralateral superior petrosal sinus. Neuroradiology (2006) 0.93
Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution? Expert Opin Pharmacother (2007) 0.93
Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism. Nephrol Dial Transplant (2006) 0.92
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia? Expert Opin Pharmacother (2007) 0.91
Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece. Eur J Gastroenterol Hepatol (2009) 0.91
A 25-year-old man with a large hepatic tumor and multiple nodular lesions. Semin Liver Dis (2002) 0.91
Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia. Ann Hematol (2006) 0.90
Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment. Open Cardiovasc Med J (2011) 0.90
Lipid-lowering agents and new onset diabetes mellitus. Expert Opin Pharmacother (2010) 0.90
Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental? Atherosclerosis (2009) 0.89
Endovascular treatment of intracranial microarteriovenous malformations. J Neurosurg (2008) 0.87
Atherogenesis in renal patients: a model of vascular disease? Curr Vasc Pharmacol (2008) 0.87
Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population. Eur J Endocrinol (2007) 0.87
Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate. Oncologist (2005) 0.87
Reversible dilated hypocalcaemic cardiomyopathy in a patient with primary hypoparathyroidism. Clin Endocrinol (Oxf) (2006) 0.87
Targeting vascular risk in patients with metabolic syndrome but without diabetes. Metabolism (2005) 0.87
Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes. Acta Diabetol (2007) 0.86
The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J (2011) 0.86
Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone? Ann Med (2011) 0.86
Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia. Respirology (2010) 0.86
Sociodemographic, ethnic and dietary factors associated with childhood obesity in Thessaloniki, Northern Greece. Hormones (Athens) (2009) 0.85
Has the time come for a new definition of microalbuminuria? Curr Vasc Pharmacol (2008) 0.85
Impact of managing atherogenic dyslipidemia on cardiovascular outcome across different stages of diabetic nephropathy. Expert Opin Pharmacother (2010) 0.85
Implementation of guidelines for the management of arterial hypertension. The impulsion study. Open Cardiovasc Med J (2009) 0.85
Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility. Endocrine (2013) 0.85
The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr Vasc Pharmacol (2010) 0.84
Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes? Curr Pharm Des (2010) 0.84
The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome. Clin Endocrinol (Oxf) (2013) 0.84
Nitric oxide and cardiobiology-methods for intact hearts and isolated myocytes. Methods Enzymol (2008) 0.83
Diabetes mellitus and cerebrovascular disease: which are the actual data? J Diabetes Complications (2008) 0.83
Insulin resistance, growth factors and cytokine levels in overweight women with breast cancer before and after chemotherapy. Hormones (Athens) (2006) 0.83
The effect of continuous positive airway pressure therapy on blood pressure and arterial stiffness in hypertensive patients with obstructive sleep apnea. Sleep Breath (2013) 0.83
Statins for the prevention of first or recurrent stroke. Curr Vasc Pharmacol (2008) 0.83
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal? Expert Opin Ther Targets (2007) 0.83
Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome. Fertil Steril (2011) 0.83
Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. Curr Vasc Pharmacol (2011) 0.83
The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration. Hormones (Athens) (2013) 0.83
Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series. Am J Hematol (2005) 0.83
Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients. Lipids (2007) 0.82
Significance of low thyroid-stimulating hormone in pregnancy. Curr Opin Endocrinol Diabetes Obes (2007) 0.82
The culture site of the gallbladder affects recovery of bacteria in symptomatic cholelithiasis. J Gastrointestin Liver Dis (2008) 0.82
Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome. Endocr J (2011) 0.82
Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients. Open Cardiovasc Med J (2007) 0.82
Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels. Curr Drug Targets (2007) 0.82
Paralysis as first manifestation of primary aldosteronism. Nephrol Dial Transplant (2004) 0.81
Ductal plate malformation and congenital hepatic fibrosis Clinical and histological findings in four patients. Hepatol Res (2006) 0.81
Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B. J Gastroenterol Hepatol (2007) 0.81
Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective? Curr Vasc Pharmacol (2010) 0.81
Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study. Curr Med Res Opin (2008) 0.80
Pegylated IFN-alpha 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B. World J Gastroenterol (2006) 0.80
The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study. Reprod Biol Endocrinol (2010) 0.80
Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome. Eur J Endocrinol (2013) 0.80
Elevated levels of serum vascular endothelial growth factor in patients with polycythaemia vera. Acta Haematol (2003) 0.80
Breakfast skipping and its relation to BMI and health-compromising behaviours among Greek adolescents. Public Health Nutr (2010) 0.80
The unilateral measurement of blood pressure may mask the diagnosis or delay the effective treatment of hypertension. Angiology (2005) 0.80
Dry cough as first manifestation of giant-cell arteritis. J Am Geriatr Soc (2006) 0.80
Prevalence and distribution of Aggregatibacter actinomycetemcomitans serotypes and the JP2 clone in a Greek population. J Clin Periodontol (2010) 0.80
In vivo effect of carbon dioxide laser-skin resurfacing and mechanical abrasion on the skin's microbial flora in an animal model. Dermatol Surg (2006) 0.80